Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baggenstoss A. H., Christensen N. A., Berge K. G., Baldus W. P., Spiekerman R. E., Ellefson R. D. Fine structural changes in the liver in hypercholesteremic patients receiving long-term nicotinic acid therapy. Mayo Clin Proc. 1967 Jul;42(7):385–399. [PubMed] [Google Scholar]
- Brown G., Albers J. J., Fisher L. D., Schaefer S. M., Lin J. T., Kaplan C., Zhao X. Q., Bisson B. D., Fitzpatrick V. F., Dodge H. T. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med. 1990 Nov 8;323(19):1289–1298. doi: 10.1056/NEJM199011083231901. [DOI] [PubMed] [Google Scholar]
- CHRISTENSEN N. A., ACHOR R. W., BERGE K. G., MASON H. L. Nicotinic acid treatment of hypercholesteremia. Comparison of plain and sustained-action preparations and report of two cases of jaundice. JAMA. 1961 Aug 26;177:546–550. doi: 10.1001/jama.1961.03040340010003. [DOI] [PubMed] [Google Scholar]
- Canner P. L., Berge K. G., Wenger N. K., Stamler J., Friedman L., Prineas R. J., Friedewald W. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol. 1986 Dec;8(6):1245–1255. doi: 10.1016/s0735-1097(86)80293-5. [DOI] [PubMed] [Google Scholar]
- Etchason J. A., Miller T. D., Squires R. W., Allison T. G., Gau G. T., Marttila J. K., Kottke B. A. Niacin-induced hepatitis: a potential side effect with low-dose time-release niacin. Mayo Clin Proc. 1991 Jan;66(1):23–28. doi: 10.1016/s0025-6196(12)61171-9. [DOI] [PubMed] [Google Scholar]
- Fischer D. J., Knight L. L., Vestal R. E. Fulminant hepatic failure following low-dose sustained-release niacin therapy in hospital. West J Med. 1991 Oct;155(4):410–412. [PMC free article] [PubMed] [Google Scholar]
- Frost P. H. All niacin is not the same. Ann Intern Med. 1991 Jun 15;114(12):1065–1065. doi: 10.7326/0003-4819-114-12-1065_1. [DOI] [PubMed] [Google Scholar]
- Henkin Y., Johnson K. C., Segrest J. P. Rechallenge with crystalline niacin after drug-induced hepatitis from sustained-release niacin. JAMA. 1990 Jul 11;264(2):241–243. [PubMed] [Google Scholar]
- Hodis H. N. Acute hepatic failure associated with the use of low-dose sustained-release niacin. JAMA. 1990 Jul 11;264(2):181–181. doi: 10.1001/jama.1990.03450020033012. [DOI] [PubMed] [Google Scholar]
- Kane J. P., Malloy M. J., Ports T. A., Phillips N. R., Diehl J. C., Havel R. J. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA. 1990 Dec 19;264(23):3007–3012. [PubMed] [Google Scholar]
- Kohn R. M., Montes M. Hepatic fibrosis following long acting nicotinic acid therapy: a case report. Am J Med Sci. 1969 Aug;258(2):94–99. doi: 10.1097/00000441-196908000-00005. [DOI] [PubMed] [Google Scholar]
- Malloy M. J., Kane J. P., Kunitake S. T., Tun P. Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia. Ann Intern Med. 1987 Nov;107(5):616–623. doi: 10.7326/0003-4819-107-5-616. [DOI] [PubMed] [Google Scholar]
- Mullin G. E., Greenson J. K., Mitchell M. C. Fulminant hepatic failure after ingestion of sustained-release nicotinic acid. Ann Intern Med. 1989 Aug 1;111(3):253–255. doi: 10.7326/0003-4819-111-3-253. [DOI] [PubMed] [Google Scholar]
- Patterson D. J., Dew E. W., Gyorkey F., Graham D. Y. Niacin hepatitis. South Med J. 1983 Feb;76(2):239–241. doi: 10.1097/00007611-198302000-00023. [DOI] [PubMed] [Google Scholar]
- Winter S. L., Boyer J. L. Hepatic toxicity from large doses of vitamin B3 (nicotinamide). N Engl J Med. 1973 Nov 29;289(22):1180–1182. doi: 10.1056/NEJM197311292892208. [DOI] [PubMed] [Google Scholar]